TRAUPIX
LIVE

Serial Number

79247605

Owner

NOVARTIS AG

Filing Date

Nov 1, 2018

Add to watchlist:

No watchlists yet
View on USPTO

TRAUPIX Trademark

Serial Number: 79247605 • Registration: 5742330

TRAUPIX is a trademark filed by NOVARTIS AG on November 1, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 1, 2018

Registration Date

May 7, 2019

Published for Opposition

February 19, 2019

Cancellation Date

November 21, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

CANCELLED SECTION 71
Nov 21, 2025 C71T
NOTIFICATION PROCESSED BY IB
Aug 23, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jul 1, 2019 FICS
FINAL DISPOSITION PROCESSED
Jul 1, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jun 6, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
May 7, 2019 R.PR
NOTIFICATION PROCESSED BY IB
Apr 26, 2019 GPNX
PUBLISHED FOR OPPOSITION
Feb 19, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 6, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 6, 2019 OP2R
NOTICE OF PUBLICATION
Jan 30, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2019 CNSA
ASSIGNED TO EXAMINER
Jan 3, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 25, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 20, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 17, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 13, 2018 SDRC